Lisa Rojkjaer, Chief Medical Officer: Viracta Therapeutics VIRX Sell · Filed 23/02/28

Trade details

Type: Insider sale
Amount: $3,622.08
Shares · price: 2,156 sh · $1.68 a share
Held after: 48,087 sh
Stock: Viracta Therapeutics VIRX
Person: Lisa RojkjaerChief Medical Officer
Trade date: 23/02/27
Filed: 23/02/28
Days to filing: 1 days

Sold 4.3% of holdings

Share of holding sold: 4.3%

Viracta Therapeutics trades, last 26 weeks

What else happened in Viracta Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/28~23/03/29

Lisa Rojkjaer's recent trades

No other trades yet.

Lisa Rojkjaer, Chief Officer — sold $3,622 of Viracta Therapeutics VIRX · 4.3% of holdings | Whalegun